Artificial intelligence (AI)-based analysis of echocardiograms has the potential to significantly reduce clinical time and expedite heart failure diagnosis wait times, according to results from the OPERA-AI study, a collaborative analysis conducted by the University of Glasgow, AstraZeneca, NHS Greater Glasgow and Clyde, and Golden Jubilee University National Hospital.
In this interview, DocWire News spoke with Dr. Ross Campbell, of the University of Glasgow, who presented the OPERA findings at the European Society of Cardiology Congress 2023. Those findings have important implications and highlight how AI may positively impact the way heart failure is diagnosed and treated in the future.